CD8A and neoplasm: Presentation of tumour‐derived antigen to CD8+ T cells by cDCs is termed cross‐presentation, a process that involves acquisition and processing of exogenous antigens that are presented in a complex with MHC‐I molecules to naïve CD8+ T cells [9, 62].